• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

重复扩展赋予微卫星不稳定癌症对 WRN 的依赖性。

Repeat expansions confer WRN dependence in microsatellite-unstable cancers.

机构信息

Laboratory of Genome Integrity, National Cancer Institute, NIH, Bethesda, MD, USA.

Department of Oncology, MRC Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford, UK.

出版信息

Nature. 2020 Oct;586(7828):292-298. doi: 10.1038/s41586-020-2769-8. Epub 2020 Sep 30.

DOI:10.1038/s41586-020-2769-8
PMID:32999459
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8916167/
Abstract

The RecQ DNA helicase WRN is a synthetic lethal target for cancer cells with microsatellite instability (MSI), a form of genetic hypermutability that arises from impaired mismatch repair. Depletion of WRN induces widespread DNA double-strand breaks in MSI cells, leading to cell cycle arrest and/or apoptosis. However, the mechanism by which WRN protects MSI-associated cancers from double-strand breaks remains unclear. Here we show that TA-dinucleotide repeats are highly unstable in MSI cells and undergo large-scale expansions, distinct from previously described insertion or deletion mutations of a few nucleotides. Expanded TA repeats form non-B DNA secondary structures that stall replication forks, activate the ATR checkpoint kinase, and require unwinding by the WRN helicase. In the absence of WRN, the expanded TA-dinucleotide repeats are susceptible to cleavage by the MUS81 nuclease, leading to massive chromosome shattering. These findings identify a distinct biomarker that underlies the synthetic lethal dependence on WRN, and support the development of therapeutic agents that target WRN for MSI-associated cancers.

摘要

RecQ DNA 解旋酶 WRN 是具有微卫星不稳定(MSI)的癌细胞的合成致死靶点,这是一种由错配修复受损引起的遗传高突变形式。WRN 的耗竭会在 MSI 细胞中诱导广泛的 DNA 双链断裂,导致细胞周期停滞和/或细胞凋亡。然而,WRN 保护 MSI 相关癌症免受双链断裂的机制尚不清楚。在这里,我们表明 TA-二核苷酸重复在 MSI 细胞中高度不稳定,并发生大规模扩展,与先前描述的少数核苷酸的插入或缺失突变明显不同。扩展的 TA 重复形成非 B DNA 二级结构,可使复制叉停滞,激活 ATR 检查点激酶,并需要 WRN 解旋酶进行解旋。在没有 WRN 的情况下,扩展的 TA-二核苷酸重复易被 MUS81 核酸内切酶切割,导致大量染色体破碎。这些发现确定了一种独特的生物标志物,该标志物是对 WRN 的合成致死依赖性的基础,并支持开发针对 MSI 相关癌症的靶向 WRN 的治疗药物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1434/8916167/4b72e80d8b5a/nihms-1781309-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1434/8916167/2950e3e67787/nihms-1781309-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1434/8916167/d5063fbbf252/nihms-1781309-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1434/8916167/e64cdf279047/nihms-1781309-f0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1434/8916167/4fb93f2e8a9b/nihms-1781309-f0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1434/8916167/c1fbc89d9987/nihms-1781309-f0009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1434/8916167/02eca8f1c4c2/nihms-1781309-f0010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1434/8916167/7e0bf839158e/nihms-1781309-f0011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1434/8916167/d42508083aa9/nihms-1781309-f0012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1434/8916167/c2f881487497/nihms-1781309-f0013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1434/8916167/def8eb4f3dc4/nihms-1781309-f0014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1434/8916167/e0d1ad398a57/nihms-1781309-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1434/8916167/1bd62d6bc97a/nihms-1781309-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1434/8916167/b54df5339d7d/nihms-1781309-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1434/8916167/4b72e80d8b5a/nihms-1781309-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1434/8916167/2950e3e67787/nihms-1781309-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1434/8916167/d5063fbbf252/nihms-1781309-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1434/8916167/e64cdf279047/nihms-1781309-f0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1434/8916167/4fb93f2e8a9b/nihms-1781309-f0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1434/8916167/c1fbc89d9987/nihms-1781309-f0009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1434/8916167/02eca8f1c4c2/nihms-1781309-f0010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1434/8916167/7e0bf839158e/nihms-1781309-f0011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1434/8916167/d42508083aa9/nihms-1781309-f0012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1434/8916167/c2f881487497/nihms-1781309-f0013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1434/8916167/def8eb4f3dc4/nihms-1781309-f0014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1434/8916167/e0d1ad398a57/nihms-1781309-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1434/8916167/1bd62d6bc97a/nihms-1781309-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1434/8916167/b54df5339d7d/nihms-1781309-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1434/8916167/4b72e80d8b5a/nihms-1781309-f0004.jpg

相似文献

1
Repeat expansions confer WRN dependence in microsatellite-unstable cancers.重复扩展赋予微卫星不稳定癌症对 WRN 的依赖性。
Nature. 2020 Oct;586(7828):292-298. doi: 10.1038/s41586-020-2769-8. Epub 2020 Sep 30.
2
WRN Is a Promising Synthetic Lethal Target for Cancers with Microsatellite Instability (MSI).WRN 是具有微卫星不稳定 (MSI) 的癌症有前途的合成致死靶标。
Cancer Treat Res. 2023;186:313-328. doi: 10.1007/978-3-031-30065-3_17.
3
WRN helicase is a synthetic lethal target in microsatellite unstable cancers.WRN 解旋酶是微卫星不稳定癌症的合成致死靶点。
Nature. 2019 Apr;568(7753):551-556. doi: 10.1038/s41586-019-1102-x. Epub 2019 Apr 10.
4
Novel WRN Helicase Inhibitors Selectively Target Microsatellite-Unstable Cancer Cells.新型 WRN 解旋酶抑制剂选择性靶向微卫星不稳定型癌细胞。
Cancer Discov. 2024 Aug 2;14(8):1457-1475. doi: 10.1158/2159-8290.CD-24-0052.
5
Comprehensive mapping of cell fates in microsatellite unstable cancer cells supports dual targeting of WRN and ATR.全面绘制微卫星不稳定癌细胞的细胞命运图谱支持 WRN 和 ATR 的双重靶向治疗。
Genes Dev. 2023 Oct 1;37(19-20):913-928. doi: 10.1101/gad.351085.123. Epub 2023 Nov 6.
6
WRN helicase and mismatch repair complexes independently and synergistically disrupt cruciform DNA structures.WRN 解旋酶和错配修复复合物独立且协同地破坏十字形 DNA 结构。
EMBO J. 2023 Feb 1;42(3):e111998. doi: 10.15252/embj.2022111998. Epub 2022 Dec 21.
7
The WRN and MUS81 proteins limit cell death and genome instability following oncogene activation.WRN 和 MUS81 蛋白限制癌基因激活后细胞死亡和基因组不稳定性。
Oncogene. 2013 Jan 31;32(5):610-20. doi: 10.1038/onc.2012.80. Epub 2012 Mar 12.
8
PROTAC-mediated conditional degradation of the WRN helicase as a potential strategy for selective killing of cancer cells with microsatellite instability.PROTAC 介导的 WRN 解旋酶条件性降解作为一种潜在的策略,用于选择性杀死具有微卫星不稳定的癌细胞。
Sci Rep. 2024 Sep 6;14(1):20824. doi: 10.1038/s41598-024-71160-5.
9
Replication fork stalling in WRN-deficient cells is overcome by prompt activation of a MUS81-dependent pathway.WRN缺陷细胞中的复制叉停滞可通过迅速激活MUS81依赖的途径来克服。
J Cell Biol. 2008 Oct 20;183(2):241-52. doi: 10.1083/jcb.200803173. Epub 2008 Oct 13.
10
Werner helicase as a therapeutic target in mismatch repair deficient colorectal cancer.沃纳解旋酶作为错配修复缺陷型结直肠癌的治疗靶点。
DNA Repair (Amst). 2025 May;149:103831. doi: 10.1016/j.dnarep.2025.103831. Epub 2025 Apr 3.

引用本文的文献

1
Synthetic lethality in cancer drug discovery: challenges and opportunities.癌症药物研发中的合成致死性:挑战与机遇
Nat Rev Drug Discov. 2025 Sep 11. doi: 10.1038/s41573-025-01273-7.
2
Synthetic Lethality-Based Targets and Their Exploration in Tumour Combination Strategies.基于合成致死性的靶点及其在肿瘤联合治疗策略中的探索
J Cell Mol Med. 2025 Aug;29(16):e70756. doi: 10.1111/jcmm.70756.
3
Mechanisms and genomic implications of break-induced replication.断裂诱导复制的机制及基因组影响

本文引用的文献

1
ATR inhibition potentiates ionizing radiation-induced interferon response via cytosolic nucleic acid-sensing pathways.ATR 抑制通过细胞质核酸感应途径增强电离辐射诱导的干扰素反应。
EMBO J. 2020 Jul 15;39(14):e104036. doi: 10.15252/embj.2019104036. Epub 2020 Jun 2.
2
On the wrong DNA track: Molecular mechanisms of repeat-mediated genome instability.在错误的 DNA 轨道上:重复介导的基因组不稳定性的分子机制。
J Biol Chem. 2020 Mar 27;295(13):4134-4170. doi: 10.1074/jbc.REV119.007678. Epub 2020 Feb 14.
3
ATM and PRDM9 regulate SPO11-bound recombination intermediates during meiosis.
Nat Struct Mol Biol. 2025 Aug 22. doi: 10.1038/s41594-025-01644-z.
4
Targeting the Werner syndrome protein in microsatellite instability cancers: mechanisms and therapeutic potential.靶向微卫星不稳定癌症中的沃纳综合征蛋白:机制与治疗潜力
Clin Exp Med. 2025 Aug 6;25(1):278. doi: 10.1007/s10238-025-01781-1.
5
Therapeutic targeting of mismatch repair-deficient cancers.错配修复缺陷型癌症的治疗靶向作用
Nat Rev Clin Oncol. 2025 Jul 10. doi: 10.1038/s41571-025-01054-6.
6
WRNexo is not required to maintain normal sex ratios in Drosophila: A CURE-Based Investigation.WRNexo并非维持果蝇正常性别比例所必需:基于CURE的研究。
MicroPubl Biol. 2025 Jun 9;2025. doi: 10.17912/micropub.biology.001620. eCollection 2025.
7
Ribosomal RNA transcription regulates splicing through ribosomal protein RPL22.核糖体RNA转录通过核糖体蛋白RPL22调节剪接。
Cell Chem Biol. 2025 Jul 17;32(7):908-925.e9. doi: 10.1016/j.chembiol.2025.05.012. Epub 2025 Jun 18.
8
A redefined InDel taxonomy provides insights into mutational signatures.重新定义的插入缺失分类法为突变特征提供了见解。
Nat Genet. 2025 May;57(5):1132-1141. doi: 10.1038/s41588-025-02152-y. Epub 2025 Apr 10.
9
Comprehensive interrogation of synthetic lethality in the DNA damage response.对DNA损伤反应中合成致死性的全面探究。
Nature. 2025 Apr;640(8060):1093-1102. doi: 10.1038/s41586-025-08815-4. Epub 2025 Apr 9.
10
Werner helicase as a therapeutic target in mismatch repair deficient colorectal cancer.沃纳解旋酶作为错配修复缺陷型结直肠癌的治疗靶点。
DNA Repair (Amst). 2025 May;149:103831. doi: 10.1016/j.dnarep.2025.103831. Epub 2025 Apr 3.
ATM 和 PRDM9 在减数分裂过程中调节 SPO11 结合的重组中间体。
Nat Commun. 2020 Feb 12;11(1):857. doi: 10.1038/s41467-020-14654-w.
4
53BP1 Enforces Distinct Pre- and Post-resection Blocks on Homologous Recombination.53BP1 对同源重组施加不同的预切除和后切除阻断。
Mol Cell. 2020 Jan 2;77(1):26-38.e7. doi: 10.1016/j.molcel.2019.09.024. Epub 2019 Oct 22.
5
Long-read sequencing for rare human genetic diseases.长读测序在罕见人类遗传疾病中的应用。
J Hum Genet. 2020 Jan;65(1):11-19. doi: 10.1038/s10038-019-0671-8. Epub 2019 Sep 27.
6
Predicting Tumor Response to PD-1 Blockade.预测肿瘤对PD-1阻断疗法的反应。
N Engl J Med. 2019 Aug 1;381(5):477-479. doi: 10.1056/NEJMcibr1906340.
7
ExpansionHunter: a sequence-graph-based tool to analyze variation in short tandem repeat regions.ExpansionHunter:一种基于序列图的工具,用于分析短串联重复区域的变异。
Bioinformatics. 2019 Nov 1;35(22):4754-4756. doi: 10.1093/bioinformatics/btz431.
8
Next-generation characterization of the Cancer Cell Line Encyclopedia.下一代癌症细胞系百科全书的特征描述。
Nature. 2019 May;569(7757):503-508. doi: 10.1038/s41586-019-1186-3. Epub 2019 May 8.
9
Genetic diversity of tumors with mismatch repair deficiency influences anti-PD-1 immunotherapy response.错配修复缺陷肿瘤的遗传多样性影响抗 PD-1 免疫治疗反应。
Science. 2019 May 3;364(6439):485-491. doi: 10.1126/science.aau0447.
10
Sequence and Nuclease Requirements for Breakage and Healing of a Structure-Forming (AT)n Sequence within Fragile Site FRA16D.断裂和修复形成结构(AT)n 序列的序列和核酸酶要求在脆性部位 FRA16D 中。
Cell Rep. 2019 Apr 23;27(4):1151-1164.e5. doi: 10.1016/j.celrep.2019.03.103.